A multidisciplinary investigation combining phytochemical isolation, computational network pharmacology, molecular docking simulations, and cell culture experiments has identified several active compounds and inflammatory signaling targets associated with the medicinal plant Dolichandrone spathacea. Chronic bronchitis, a respiratory condition characterized by a persistent cough with mucus production lasting over three months in two consecutive years, commonly coexists with chronic obstructive pulmonary disease and is driven by airway obstruction, goblet cell hyperplasia, and chronic inflammation mediated largely by macrophages. In traditional medicine systems across Vietnam and India, preparations of Dolichandrone spathacea, a Bignoniaceae tree native to riverbanks and mangrove ecosystems throughout the Asia-Pacific region, have long been utilized to alleviate chronic bronchitis, asthma, and various inflammatory conditions. However, the precise chemical constituents and underlying molecular mechanisms remained incompletely defined, prompting the research team to systematically isolate key phytoconstituents, computationally model multi-target biological interactions, and experimentally validate anti-inflammatory efficacy in cultured macrophage cells.
To investigate the chemical profile of the plant, botanical material was obtained from the Hospital of Traditional Medicine in Ho Chi Minh City, Vietnam, and genetically verified through amplification and Sanger sequencing of the rbcL gene region. A dried mass of 3.0 kilograms of the botanical material was extracted three times with 95 percent ethanol over seven days at room temperature, yielding 400 grams of crude extract following solvent evaporation under reduced pressure at 45 degrees Celsius. Subsequent liquid-liquid partitioning dispersed the crude extract in water and partitioned it consecutively with n-hexane, ethyl acetate, and n-butanol. Chromatographic separation of the ethyl acetate fraction on normal-phase and reverse-phase semi-preparative high-performance liquid chromatography columns allowed the team to isolate three specific compounds: beta-sitosterol, 6-O-trans-p-coumaroyl ajugol, and 6-O-[(E)-4-methoxycinnamoyl]catalpol. The chemical structures of these compounds were elucidated using one-dimensional and two-dimensional nuclear magnetic resonance spectroscopy, high-resolution electrospray ionization mass spectrometry, and comparisons with published literature values, marking the first reported isolation of beta-sitosterol from this particular species.
By pooling the newly isolated compounds with previously reported chemical constituents documented in scientific literature, the researchers compiled a dataset of 59 phytochemicals associated with Dolichandrone spathacea. To transition from broad chemical profiles to potential biological interactions, SwissTargetPrediction was employed with the Homo sapiens parameter, retaining potential protein targets that demonstrated a prediction probability of at least 0.1, which narrowed the active chemical library to 49 compounds. MolSoft drug-likeness scoring was simultaneously calculated from molecular SMILES strings, identifying 30 bioactive compounds that exhibited positive drug-likeness values, among which salvionoside B achieved the highest score of 0.79. In parallel, disease-related targets were gathered from GeneCards and DrugBank using the search term chronic bronchitis, yielding 323 prospective genes with relevance scores of at least 10 from GeneCards alongside 104 genes linked to 18 approved bronchitis pharmaceuticals. Removing redundancies produced 381 non-redundant human genes associated with chronic bronchitis pathology.
The intersection between the 386 predicted targets of Dolichandrone spathacea constituents and the 381 disease-associated genes yielded a core network of 66 overlapping target genes, which were visualized using Cytoscape software. A protein-protein interaction network constructed through the STRING database with human species parameters revealed that these 66 shared targets formed 559 interaction edges, displaying an average node degree of 16.9 and a highly significant enrichment p-value below 1.0e-16. Topological evaluation based on node degrees exceeding twice the average identified eight core hub targets within the network: TNF, AKT1, SRC, EGFR, IL2, MMP-9, HSP90AA1, and PTGS2. Among these, tumor necrosis factor (TNF) exhibited the highest degree score of 49, followed closely by AKT1 with 42, SRC and EGFR with 39, IL2 with 37, MMP-9 and HSP90AA1 with 35, and PTGS2 with 34, underscoring their central positioning in mediating inflammatory signaling and cellular responses.
Functional annotation of the 66 overlapping genes through the Database for Annotation, Visualization and Integrated Discovery identified 351 statistically significant Gene Ontology terms across biological processes, cellular components, and molecular functions. Biological process enrichment highlighted prominent involvement in cellular responses to lipopolysaccharide, peptidyl-tyrosine phosphorylation, negative regulation of apoptotic processes, signal transduction, and positive regulation of MAP kinase activity. Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed significant enrichment in 107 pathways at a threshold of p less than 0.01, with the TNF signaling pathway and the IL-17 signaling pathway ranking among the primary mechanisms relevant to chronic bronchitis. Further network intersection between the top eight hub genes and these prioritized pathways highlighted three pivotal genes—PTGS2, TNF, and MMP-9—as central nodes operating concurrently within both the TNF and IL-17 cascades to govern inflammatory mediator release and tissue remodeling.
Pharmacokinetic and toxicokinetic predictions conducted through the admetSAR 2.0 platform provided absorption, distribution, metabolism, excretion, and toxicity profiles for the candidate constituents. Several bioactives, including dolichandrone B, uncaric acid, oleanolic acid, ursolic acid, pomolic acid, beta-sitosterol, and 5alpha-stigmastane-3,6-dione, were predicted to display favorable human intestinal absorption probabilities exceeding 85 percent. The computational screen indicated that all evaluated compounds are metabolized by cytochrome P450 3A4 and act as inhibitors of CYP2C8, while nearly all compounds demonstrated strong potential binding to plasma proteins, with the notable exception of ursolic acid. Six prominent compounds—luteolin, dolichandrone B, salvionoside B, uncaric acid, oleanolic acid, and ursolic acid—emerged from the compound-target network as master regulators that directly interacted with multiple core target proteins involved in the inflammatory cascade.
To evaluate the structural feasibility of these interactions, molecular docking simulations were carried out using the CDOCKER algorithm in Discovery Studio software against the crystallographic structures of TNFR1, COX-2, and MMP-9. Receptors and ligands underwent energy minimization under the CHARMm force field prior to flexible docking into defined receptor binding spheres, with lower docking affinity values reflecting stronger thermodynamic interactions. The computational models demonstrated that the key bioactive compounds possessed high binding affinities across the receptor panel, frequently surpassing the docking scores of the positive control drug aspirin. Specifically, salvionoside B exhibited the strongest binding affinity toward COX-2 at negative 66.5444 kilocalories per mole, forming extensive hydrogen bonds with residues Ala202, Thr206, His207, Thr212, His214, Thr292, Asn382, and Tyr385, complemented by alkyl and pi-alkyl interactions. Dolichandrone B similarly engaged COX-2 with an affinity of negative 65.4134 kilocalories per mole, substantially outperforming aspirin’s docking score of negative 30.6013 kilocalories per mole.
Docking simulations against the remaining core receptors demonstrated that oleanolic acid achieved the highest affinity for TNFR1 at negative 58.8954 kilocalories per mole, stabilized by hydrogen bonding with TyrB59 and GlyA121, alongside hydrophobic contacts with surrounding residues. In the active site of MMP-9, luteolin displayed the strongest binding interaction with a docking affinity of negative 11.6525 kilocalories per mole. Crucially, luteolin formed a metal-acceptor coordinate bond with the catalytic zinc ion Zn301, a contact recognized as essential for the enzymatic inhibition of matrix metalloproteinases, while establishing supplementary hydrogen bonds with Gly186, His236, and Pro246. These computational models suggest that multiple phytoconstituents found in the plant possess complementary molecular geometries capable of simultaneously binding and modulating receptors that govern cytokine transcription and extracellular matrix degradation.
The computational predictions were subsequently tested in vitro using mouse macrophage RAW 264.7 cell cultures stimulated with lipopolysaccharide. Prior to inflammatory assays, extract cytotoxicity was evaluated across concentrations of 200 and 400 micrograms per milliliter using standard MTT colorimetric assays, confirming acceptable cellular tolerance. Nitric oxide secretion was determined by quantifying nitrite levels via the Griess reagent in cell supernatants pretreated with the botanical ethanol extract at doses of 20, 100, 200, and 400 micrograms per milliliter followed by 24 hours of lipopolysaccharide exposure. The ethanol extract exhibited dose-dependent suppression of nitric oxide production, yielding an IC50 value of 25.34 micrograms per milliliter. At extract concentrations of 100 and 200 micrograms per milliliter, nitric oxide release was inhibited by more than 86 percent and 91 percent, respectively, demonstrating pronounced efficacy in attenuating macrophage-mediated nitrosative stress.
The capacity of the botanical extract to suppress pro-inflammatory cytokine expression was measured using enzyme-linked immunosorbent assays for TNF-alpha and IL-1beta in RAW 264.7 macrophage cultures stimulated with lipopolysaccharide. At a treatment concentration of 100 micrograms per milliliter, the ethanol extract achieved a 71.67 percent reduction in TNF-alpha production and a 90.22 percent reduction in IL-1beta production. When compared to the reference non-steroidal anti-inflammatory drug aspirin applied at the identical concentration of 100 micrograms per milliliter, the botanical extract demonstrated comparable or superior cytokine suppression. Residual TNF-alpha levels reached 99.155 picograms per milliliter in extract-treated cells versus 109.500 picograms per milliliter in aspirin-treated cultures, while IL-1beta decreased substantially from 23.835 picograms per milliliter in lipopolysaccharide-only controls to 2.339 picograms per milliliter in the botanical group, compared to 11.669 picograms per milliliter with aspirin.
Collectively, these integrated findings provide a mechanistic framework explaining how Dolichandrone spathacea exerts multi-target anti-inflammatory activity relevant to chronic bronchitis management. By isolating stable phytoconstituents such as beta-sitosterol, mapping regulatory networks across hub targets including TNF, PTGS2, and MMP-9, and demonstrating significant suppression of nitric oxide, TNF-alpha, and IL-1beta in cell culture, the study elucidates how traditional botanical therapies may simultaneously influence multiple nodes of the TNF and IL-17 signaling pathways. Nonetheless, the authors emphasize that while in silico docking and in vitro macrophage assays demonstrate robust biological activity, these cell-based findings do not establish direct clinical efficacy in human patients, warranting further in vivo pharmacokinetic and clinical evaluations to determine therapeutic bioavailability and safety.
Subject of Research: Phytochemical isolation, network pharmacology, and anti-inflammatory evaluation of Dolichandrone spathacea for chronic bronchitis
Article Title: Isolation of phytochemicals and exploration the mechanism of Dolichandrone spathacea in the treatment of chronic bronchitis by integrating network pharmacology, molecular docking, and experimental validation
Article References: Nguyen, D.-K., Liu, T.-W., Chu, M.-H., Huynh, Q.-D. T., Duong, T.-L. T., Phan, T.-T. T., Huynh, D. T. M., Wang, Y.-H., Wang, S.-M., Hsu, S.-J., & Lee, C.-K. (2025). Isolation of phytochemicals and exploration the mechanism of Dolichandrone spathacea in the treatment of chronic bronchitis by integrating network pharmacology, molecular docking, and experimental validation. Botanical Studies, 66(1), Article 24. https://doi.org/10.1186/s40529-025-00464-0
Image Credits: AI Generated
DOI: 10.1186/s40529-025-00464-0
Keywords: Dolichandrone spathacea, chronic bronchitis, network pharmacology, molecular docking, phytochemicals, inflammation, RAW 264.7 cells, TNF signaling pathway, Isolation, exploration, mechanism, Dolichandrone
News Source: Drew Townsend. (November 10, 2026). Study Uncovers Botanical Compounds and Mechanisms Targeting Chronic Bronchitis Inflammation. Scienmag.



